These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6175838)

  • 1. Central and peripheral alpha-adrenoceptors.
    van Zwieten PA; van Meel JC; de Jonge A; Wilffert B; Timmermans PB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S19-24. PubMed ID: 6175838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine.
    Timmermans PB; Schoop AM; Kwa HY; Van Zwieten PA
    Eur J Pharmacol; 1981 Mar; 70(1):7-15. PubMed ID: 6111465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors.
    Van Meel JC; de Jonge A; Kalkman HO; Wilffert B; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jul; 316(4):288-93. PubMed ID: 6115322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
    van Zwieten PA; van Meel JC; Timmermans PB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
    Van Zwieten PA
    Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha 1- and alpha 2-adrenoceptor involvement in the central cardiovascular action of clonidine in the conscious renal hypertensive cat.
    Beckett PJ; Finch L
    Eur J Pharmacol; 1982 Aug; 82(3-4):155-60. PubMed ID: 6127223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of alpha 2-adrenoceptors to the central cardiovascular effects of clonidine and S 8350 in anaesthetized rats.
    Deckert V; Lachaud V; Parini A; Elghozi JL
    Clin Exp Pharmacol Physiol; 1991 Oct; 18(10):401-8. PubMed ID: 1684919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.
    Hamilton TC; Longman SD
    Br J Pharmacol; 1982 Jan; 75(1):13-21. PubMed ID: 6122478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
    J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues.
    de Jonge A; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):8-12. PubMed ID: 6116198
    [No Abstract]   [Full Text] [Related]  

  • 14. DJ-7141, a new alpha-2 agonist with only a mild hypotensive action.
    Muramatsu I; Oshita M; Hashimoto S; Kigoshi S
    Jpn J Pharmacol; 1986 May; 41(1):61-8. PubMed ID: 2874252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central alpha-adrenoceptors involved in cardiovascular regulation.
    Häusler G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S72-6. PubMed ID: 6175849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nifedipine on functional responses in vivo initiated at alpha 2-adrenoceptors.
    Timmermans PB; de Jonge A; van Meel JC; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(1):1-11. PubMed ID: 6186842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.
    Drew GM; Gower AJ; Marriott AS
    Br J Pharmacol; 1979 Sep; 67(1):133-41. PubMed ID: 40643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.